Literature DB >> 7263762

Investigation results of a comparison made between the Kiel and Rappaport classifications of the non-Hodgkin's lymphomas, together with clinical data.

K Musshoff, W von Stotzingen, H Schmidt-Vollmer, H Umbach.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7263762     DOI： 10.1007/BF00403365

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  24 in total

1.  Preliminary clinical findings on the Kiel classification of malignant lymphomas.

Authors:  K Musshoff; H Schmidt-Vollmer; K Lennert; W Sandritter
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-09

2.  Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classification.

Authors:  P Meusers; H Bartels; G Brittinger; H Common; E Dühmke; H H Fülle; U Gunzer; R Heniz; E König; K Musshoff; H Pralle; U Schmalhorst; H Theml; G R Krüger; K Lennert
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

3.  Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  Non-Hodgkin malignant lymphomas. Clinico-pathologic correlations with the Kiel classification. Retrospective analysis of a series of 274 cases.

Authors:  C Meugé; B Hoerni; A de Mascarel; M Durand; P Richaud; G Hoerni-Simon; J Chauvergne; C Lagarde
Journal:  Eur J Cancer       Date:  1978-05       Impact factor: 9.162

5.  Carcinoma of the nasopharynx--the significance of histology.

Authors:  R T Hoppe; J Williams; R Warnke; D R Goffinet; M A Bagshaw
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Mar-Apr       Impact factor: 7.038

6.  Team approach to management of non-Hodgkin's lymphomas: past and present.

Authors:  L M Fuller; J F Gamble; J J Butler; J G Sinkovics; S Wallace; R G Martin; E A Gehan; C C Shullenberger
Journal:  Cancer Treat Rep       Date:  1977-09

7.  Cytological and functional criteria for the classification of malignant lymphomata.

Authors:  K Lennert; H Stein; E Kaiserling
Journal:  Br J Cancer Suppl       Date:  1975-03

8.  Reticulum cell sarcoma, an oncologic model for a system of classifying the malignant lymphomas.

Authors:  K Musshoff; H Schmidt-Vollmer; D Merten
Journal:  Eur J Cancer       Date:  1971-10       Impact factor: 9.162

9.  Survival of patients with localized histiocytic lymphoma.

Authors:  J D Bitran; J Kinzie; D L Sweet; D Variakojis; M L Griem; H M Golomb; J B Miller; N Oetzel; J E Ultmann
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

10.  Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

Authors:  P S Schein; V T DeVita; S Hubbard; B A Chabner; G P Canellos; C Berard; R C Young
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391
View more
  3 in total

1.  Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas.

Authors:  P van der Valk; A Mosch; P J Kurver; C J Meijer
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

2.  Morphometric characterization of diffuse large-cell (histiocytic) lymphomas.

Authors:  P van der Valk; J Hermans; R Brand; C J Cornelisse; P J Spaander; C J Meijer
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

3.  Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the "working formulation".

Authors:  W M Molenaar; H Bartels; J Koudstaal
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.